Stem Point Capital LP Wave Life Sciences Ltd. Transaction History
Stem Point Capital LP
- $401 Billion
- Q4 2024
A detailed history of Stem Point Capital LP transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Stem Point Capital LP holds 721,209 shares of WVE stock, worth $6.77 Million. This represents 2.23% of its overall portfolio holdings.
Number of Shares
721,209
Previous 300,000
140.4%
Holding current value
$6.77 Million
Previous $2.46 Billion
262.66%
% of portfolio
2.23%
Previous 0.74%
Shares
2 transactions
Others Institutions Holding WVE
# of Institutions
192Shares Held
122MCall Options Held
430KPut Options Held
330K-
Ra Capital Management, L.P. Boston, MA18.2MShares$171 Million3.65% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.62MShares$90.4 Million0.22% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx8.26MShares$77.6 Million1.98% of portfolio
-
Black Rock Inc. New York, NY6.74MShares$63.3 Million0.0% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.71MShares$63 Million0.81% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $815M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...